RP-HPLC-Based Stability-Indicating Analytical Method for Concurrent Determination of Finasteride and Tadalafil: Development and Validation
January 2025
in “
International Journal of Drug Delivery Technology
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → 
Studysummary In this study, researchers developed a reliable HPLC method to simultaneously estimate Finasteride and Tadalafil in marketed formulations, showing precise, linear results with confirmed degradation susceptibility under certain stress conditions.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
A stability-indicating RP-HPLC method was developed and validated for the simultaneous estimation of Finasteride and Tadalafil, demonstrating effective separation and high precision with a linearity range of 12.5–75 µg/mL and R² > 0.999. The method showed excellent precision (%RSD < 2%) and sensitivity with LOD/LOQ values of 0.60 µg/mL and 2.00 µg/mL. Assay results for the marketed formulation ENTADFI were 100.0% for Finasteride and 100.2% for Tadalafil. Forced degradation studies revealed that both drugs are susceptible to degradation under various stress conditions, with Finasteride showing maximum degradation under acidic (14.0%) and oxidative (14.7%) conditions, and Tadalafil under alkali (10.8%) and reduction (14.6%) conditions, while minimal degradation occurred under thermal and hydrolytic conditions.
